Dr. Alharthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St, S9D
Baltimore, MD 21201Phone+1 410-328-7609
Education & Training
University of MarylandResidency, Internal Medicine, 2019 - 2022
OtherClass of 2015, MBBS
Certifications & Licensure
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha
Haematologica. 2024-11-14 - Chronic myeloid leukemia presenting as an atraumatic splenic rupture in the setting of coronavirus disease 2019 infection.Hanan Alharthy, Jaclyn Clark, Rima Koka, Ali Aldahmashi, Maria R Baer
Ejhaem. 2023-05-01 - 1 citationsA Case of Acute Myeloid Leukemia-Associated Necrotizing Sweet Syndrome.Jennifer Strong, Albert E Zhou, Fahad Alkaabba, Danielle Soldin, Joanne Moon
Case Reports in Dermatology. 2022-11-07
Abstracts/Posters
- FDG-PET Utilizing Deauville Scoring Is Superior to Conventional Imaging for Staging and Response Assessment in Pediatric and Adult Patients with Nodular Lymphocyte Pre...M S Rauf, MD , Z A Khan, MD , M N Zahir, MD , Suleimman Al-Sweedan, MD , Amani Al-Kofide, MD , Hannan Alharthy, MD , Fahad A Almugbel, MD , Asif Osmani, MD , I..., Blood (2017) 130 (Supplement 1): 1519.
Professional Memberships
- Member
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
